Board of Directors

Chairman:
Philippe Stas, Lonza (UK)

Board members:
Christian Ross, Novo Nordisk (DK), vice-chairman
Huub Schellekens, Utrecht University (NL), vice-chairman

Nina Brenden, AstraZeneca (SE)
Julia Heinrich, Roche (DE)
Hishani Kirby, UCB Celltech (UK)
Daniel Kramer, Merck-Serono (DE)
Arno Kromminga, IPM Biotech (DE)
Sebastian Spindeldreher, Novartis (CH)

Administrator:
Barbara Vercruyssen